Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment
Antioxidants · 16.11.2024 · 13 (11) · 1405
DOI: 10.3390/antiox13111405 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 16.11.2024. Verfasst von Paula Iglesias-Matesanz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Genomics and Therapeutics in Prostate Cancer Group, I+12 Biomedical Research Institute, 28041 Madrid, Spain. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Council, Spanish Pancreatic Cancer Association, ALADDIN—Accelerated Discovery Nanobody Platform.
Abstract (Originalsprache)
Glutathione peroxidases (GPxs) are a family of enzymes that play a critical role in cellular redox homeostasis through the reduction of lipid hydroperoxides to alcohols, using glutathione as a substrate. Among them, GPx4 is particularly of interest in the regulation of ferroptosis, a form of iron-dependent programmed cell death driven by the accumulation of lipid peroxides in the endoplasmic reticulum, mitochondria, and plasma membrane. Ferroptosis has emerged as a crucial pathway in the context of cancer, particularly pancreatic cancer, which is notoriously resistant to conventional therapies. GPx4 acts as a key inhibitor of ferroptosis by detoxifying lipid peroxides, thereby preventing cell death. However, this protective mechanism also enables cancer cells to survive under oxidative stress, which makes GPx4 a potential druggable target in cancer therapy. The inhibition of GPx4 can trigger ferroptosis selectively in cancer cells, especially in those that rely heavily on this pathway for survival, such as pancreatic cancer cells. Consequently, targeting GPx4 and other GPX family members offers a promising therapeutic strategy to sensitize pancreatic cancer cells to ferroptosis, potentially overcoming resistance to current treatments and improving patient outcomes. Current research is focusing on the development of small-molecule inhibitors of GPx4 as potential candidates for pancreatic cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genomics and Therapeutics in Prostate Cancer Group, I+12 Biomedical Research Institute, 28041 Madrid, Spain.
- START Madrid-FJD, Hospital Fundacion Jimenez Diaz, 28040 Madrid, Spain.
- Translational Oncology Division, OncoHealth Institute, Health Research Institute Fundación Jimenez Diaz, Fundación Jimenez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
- Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040 Madrid, Spain.
- Area of Physiology, Department of Basic Health Sciences, Faculty of Health Sciences, Rey Juan Carlos University, 28922 Madrid, Spain.
ORCID-Profile: Javier Martinez-Useros
Förderung
- European Council
- Spanish Pancreatic Cancer Association
- ALADDIN—Accelerated Discovery Nanobody Platform
- Spanish Pancreatic Cancer Association: “5th Beca Carmen Delgado/Miguel Pérez-Mateo-AESPANC-ACANPAN”
Zitieren
APA
Iglesias-Matesanz, P., Lacalle-Gonzalez, C., Lopez-Blazquez, C., Ochieng' Otieno, M., Garcia-Foncillas, J., & Martinez-Useros, J. (2024). Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment. Antioxidants, 13(11), 1405. https://doi.org/10.3390/antiox13111405
Vancouver
Iglesias-Matesanz P, Lacalle-Gonzalez C, Lopez-Blazquez C, Ochieng' Otieno M, Garcia-Foncillas J, Martinez-Useros J. Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment. Antioxidants. 2024;13(11):1405. doi:10.3390/antiox13111405
BibTeX
@article{IglesiasMatesanz2024,
author = {Iglesias-Matesanz, Paula and Lacalle-Gonzalez, Carlos and Lopez-Blazquez, Carlos and Ochieng' Otieno, Michael and Garcia-Foncillas, Jesus and Martinez-Useros, Javier},
title = {Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {11},
pages = {1405},
doi = {10.3390/antiox13111405}
}
EUVIMED